Hypertension effective treatment coverage (controlled hypertension) in Tajikistan
Tajikistan: Hypertension effective treatment coverage (controlled hypertension) was 7.4% in 2019. ▲ Rising
Hypertension effective treatment coverage (controlled hypertension) in Tajikistan, 1990–2019
Source: World Health Organization, Global Health Observatory.
Analysis
In 2019, hypertension effective treatment coverage (controlled hypertension) in Tajikistan stood at 7.4%. That is the highest value across all 30 years on record.
The figure is up 1.4% on the previous year and up 5.7% over ten years.
Over the whole period, hypertension effective treatment coverage (controlled hypertension) in Tajikistan peaked at 7.4% in 2019 and was at its lowest, 3.1%, in 1990.
That places Tajikistan 179th out of 193 countries with data for 2019, putting it in the bottom quarter.
The long-run direction has been consistently rising across the 30 years of available data.
Hypertension effective treatment coverage (controlled hypertension) in Tajikistan, year by year
| Year | Value | Change |
|---|---|---|
| 1990 | 3.1% | — |
| 1991 | 3.1% | +0.0% |
| 1992 | 3.2% | +3.2% |
| 1993 | 3.3% | +3.1% |
| 1994 | 3.4% | +3.0% |
| 1995 | 3.6% | +5.9% |
| 1996 | 3.8% | +5.6% |
| 1997 | 4.0% | +5.3% |
| 1998 | 4.2% | +5.0% |
| 1999 | 4.5% | +7.1% |
| 2000 | 4.7% | +4.4% |
| 2001 | 5.0% | +6.4% |
| 2002 | 5.3% | +6.0% |
| 2003 | 5.7% | +7.5% |
| 2004 | 6.0% | +5.3% |
| 2005 | 6.3% | +5.0% |
| 2006 | 6.5% | +3.2% |
| 2007 | 6.8% | +4.6% |
| 2008 | 6.9% | +1.5% |
| 2009 | 7.0% | +1.4% |
| 2010 | 7.1% | +1.4% |
| 2011 | 7.2% | +1.4% |
| 2012 | 7.2% | +0.0% |
| 2013 | 7.2% | +0.0% |
| 2014 | 7.2% | +0.0% |
| 2015 | 7.2% | +0.0% |
| 2016 | 7.2% | +0.0% |
| 2017 | 7.2% | +0.0% |
| 2018 | 7.3% | +1.4% |
| 2019 | 7.4% | +1.4% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1990s | 3.6% | 3.1% | 4.5% | 10 |
| 2000s | 6.0% | 4.7% | 7.0% | 10 |
| 2010s | 7.2% | 7.1% | 7.4% | 10 |
Countries ranked near Tajikistan
More health data for Tajikistan
- Un projection of annual infant deaths, annual growth rate -1.94 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.9561 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 887 deaths per 1,000 people (2090)
- Number of infants who die before age 1 1,061 deaths (2100)
- Population ages 40-44, male, annual growth rate 5.2 % change on previous year (2025)
- Population ages 40-44, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 40-44, male, per capita 0.0272 units per person (2025)
- Population ages 45-49, female, annual growth rate 3.22 % change on previous year (2025)
- Population ages 45-49, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 45-49, female, per capita 0.0226 units per person (2025)
Frequently asked questions
- What is hypertension effective treatment coverage (controlled hypertension) in Tajikistan?
- Hypertension effective treatment coverage (controlled hypertension) in Tajikistan was 7.4% in 2019, according to World Health Organization, Global Health Observatory.
- What is the highest hypertension effective treatment coverage (controlled hypertension) recorded in Tajikistan?
- The highest recorded value was 7.4% in 2019.
- What is the lowest hypertension effective treatment coverage (controlled hypertension) recorded in Tajikistan?
- The lowest recorded value was 3.1% in 1990.
- How does Tajikistan rank for hypertension effective treatment coverage (controlled hypertension)?
- Tajikistan ranks 179th out of 193 countries with data for 2019.
- Is hypertension effective treatment coverage (controlled hypertension) rising or falling in Tajikistan?
- Over the last ten years it is up 5.7%. The long-run trend across the full record is rising.
- Where does this Tajikistan data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Hypertension effective treatment coverage (controlled hypertension )among adults aged 30-79, age-standardized (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 30 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).